BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 38042167)

  • 21. Cost-effectiveness and health impact of lung cancer screening with low-dose computed tomography for never smokers in Japan and the United States: a modelling study.
    Kowada A
    BMC Pulm Med; 2022 Jan; 22(1):19. PubMed ID: 34996423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial.
    Balekian AA; Tanner NT; Fisher JM; Silvestri GA; Gould MK
    Ann Am Thorac Soc; 2016 Sep; 13(9):1568-74. PubMed ID: 27387658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study.
    Marquette CH; Boutros J; Benzaquen J; Ferreira M; Pastre J; Pison C; Padovani B; Bettayeb F; Fallet V; Guibert N; Basille D; Ilie M; Hofman V; Hofman P;
    Lancet Respir Med; 2020 Jul; 8(7):709-716. PubMed ID: 32649919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The BUILT study: a single-center 5-year experience of Lung Cancer screening in Taiwan.
    Wu CW; Ku YT; Huang CY; Hsieh PC; Lim KE; Tzeng IS; Lan CC; Wu YK; Hsu YC
    Int J Med Sci; 2021; 18(16):3861-3869. PubMed ID: 34790062
    [No Abstract]   [Full Text] [Related]  

  • 25. [Analysis of low-dose computed tomography compliance and related factors among high-risk population of lung cancer in three provinces participating in the cancer screening program in urban China].
    Wen Y; Yu LZ; Du LB; Wei DH; Liu YY; Yang ZY; Zheng YD; Wu Z; Yu XY; Zhao L; Yu YW; Chen HD; Ren JS; Qin C; Xu YJ; Cao W; Wang F; Li J; Tan FW; Dai M; Chen WQ; Li N; He J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 May; 55(5):633-639. PubMed ID: 34034404
    [No Abstract]   [Full Text] [Related]  

  • 26. [Risk factors for lung cancer based on low-dose computed tomography screening].
    Jin YJ; Tang W; Huang Y; Wang JW; Hou DH; Qi LL; Zhao SJ; Wu N
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):222-227. PubMed ID: 32252201
    [No Abstract]   [Full Text] [Related]  

  • 27. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial.
    Croswell JM; Baker SG; Marcus PM; Clapp JD; Kramer BS
    Ann Intern Med; 2010 Apr; 152(8):505-12, W176-80. PubMed ID: 20404381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral arterial disease and systematic detection of circulating tumor cells: rationale and design of the DETECTOR prospective cohort study.
    Yannoutsos A; Fontaine M; Galloula A; Damotte D; Chatellier G; Paterlini-Bréchot P; Meyer G; Pastre J; Duchatelle V; Marini V; Schwering KL; Lazareth I; Ghaffari P; Stansal A; Sanson H; Labrousse C; Beaussier H; Nasr NB; Zins M; Salmeron S; Messas E; Lajonchère JP; Emmerich J; Priollet P; Trédaniel J
    BMC Cardiovasc Disord; 2019 Sep; 19(1):212. PubMed ID: 31519196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort.
    Ruparel M; Quaife SL; Dickson JL; Horst C; Tisi S; Hall H; Taylor MN; Ahmed A; Shaw PJ; Burke S; Soo MJ; Nair A; Devaraj A; Sennett K; Hurst JR; Duffy SW; Navani N; Bhowmik A; Baldwin DR; Janes SM
    Ann Am Thorac Soc; 2020 Jul; 17(7):869-878. PubMed ID: 32164439
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessment of Selection Criteria for Low-Dose Lung Screening CT Among Asian Ethnic Groups in Taiwan: From Mass Screening to Specific Risk-Based Screening for Non-Smoker Lung Cancer.
    Wu FZ; Huang YL; Wu CC; Tang EK; Chen CS; Mar GY; Yen Y; Wu MT
    Clin Lung Cancer; 2016 Sep; 17(5):e45-e56. PubMed ID: 27133540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-risk older smokers' perceptions, attitudes, and beliefs about lung cancer screening.
    Cataldo JK
    Cancer Med; 2016 Apr; 5(4):753-9. PubMed ID: 26822940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta.
    Osarogiagbon RU; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Qureshi T; Matthews AT; Smeltzer MP; Pinsky PF
    JAMA Netw Open; 2023 Feb; 6(2):e230787. PubMed ID: 36848089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting Lung Cancer Occurrence in Never-Smoking Females in Asia: TNSF-SQ, a Prediction Model.
    Chien LH; Chen CH; Chen TY; Chang GC; Tsai YH; Hsiao CF; Chen KY; Su WC; Wang WC; Huang MS; Chen YM; Chen CY; Liang SK; Chen CY; Wang CL; Lee MH; Chung RH; Tsai FY; Hu JW; Katki HA; Chatterjee N; Chanock SJ; Rothman N; Lan Q; Yang PC; Chen CJ; Chang IS; Hsiung CA
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):452-459. PubMed ID: 31848206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).
    Blanchon T; Bréchot JM; Grenier PA; Ferretti GR; Lemarié E; Milleron B; Chagué D; Laurent F; Martinet Y; Beigelman-Aubry C; Blanchon F; Revel MP; Friard S; Rémy-Jardin M; Vasile M; Santelmo N; Lecalier A; Lefébure P; Moro-Sibilot D; Breton JL; Carette MF; Brambilla C; Fournel F; Kieffer A; Frija G; Flahault A;
    Lung Cancer; 2007 Oct; 58(1):50-8. PubMed ID: 17624475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low positive predictive value of computed tomography screening for lung cancer irrespective of commonly employed definitions of target population.
    Krilaviciute A; Brenner H
    Int J Cancer; 2021 Jul; 149(1):58-65. PubMed ID: 33634860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
    Patz EF; Greco E; Gatsonis C; Pinsky P; Kramer BS; Aberle DR
    Lancet Oncol; 2016 May; 17(5):590-9. PubMed ID: 27009070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary results of low-dose computed tomography screening for lung cancer in asymptomatic participants.
    Deng Y; Xiong Z; Mao X; Zhou L; Guo F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):244-251. PubMed ID: 35545415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung cancer screening with low-dose computed tomography: Canadian experience.
    Roberts HC; Patsios D; Paul NS; McGregor M; Weisbrod G; Chung T; Herman S; Boerner S; Waddell T; Keshavjee S; Darling G; Pereira A; Kale A; Bayanati H; Sitartchouk I; Tsao M; Shepherd FA
    Can Assoc Radiol J; 2007 Oct; 58(4):225-35. PubMed ID: 18186434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose CT: a useful and accessible tool for the early diagnosis of lung cancer in selected populations.
    Callol L; Roig F; Cuevas A; de Granda JI; Villegas F; Jareño J; Arias E; Albiach JM
    Lung Cancer; 2007 May; 56(2):217-21. PubMed ID: 17316889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of Subsolid Nodules in Lung Cancer Screening: Complementary Sensitivity of Visual Reading and Computer-Aided Diagnosis.
    Silva M; Schaefer-Prokop CM; Jacobs C; Capretti G; Ciompi F; van Ginneken B; Pastorino U; Sverzellati N
    Invest Radiol; 2018 Aug; 53(8):441-449. PubMed ID: 29543693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.